跳至主要内容
临床试验/NCT06315179
NCT06315179招募中不适用

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation

Seattle Children's Hospital2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年5月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
2
主要终点
Bio-repository sample collection for spatial transcriptomics

研究概览

简要总结

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.

详细描述

Research procedures will coincide with clinical visits at institutional standards. As part of their clinical disease evaluation, participants will have blood, stool, and tissue collected as indicated by their disease course. Additional research samples or data will be collected during these visits. Participants will be asked to collect urine samples specifically for research.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC)

排除标准

  • Evidence of Other Complicating Medical Issues:
  • Other serious medical conditions, such as neurological, liver, kidney, or systemic disease
  • Pregnancy
  • Tobacco, alcohol, or illicit drug abuse

研究组 & 干预措施

Inflammatory Bowel Disease

Participants will enroll before their initial diagnostic procedure. After pathology results are reported, participants will be categorized based on the assigned diagnoses: Inflammatory Bowel Disease (IBD) [Crohn's disease (CD), ulcerative colitis (UC), and Indeterminate Colitis (IC)] vs Disorders of the Brain-Gut Interactions (DGBI).

Participation in the IBD cohort will last for three years.

干预措施: Esophagogastroduodenoscopy (EGD) with biopsy (Diagnostic Test)

Inflammatory Bowel Disease

Participants will enroll before their initial diagnostic procedure. After pathology results are reported, participants will be categorized based on the assigned diagnoses: Inflammatory Bowel Disease (IBD) [Crohn's disease (CD), ulcerative colitis (UC), and Indeterminate Colitis (IC)] vs Disorders of the Brain-Gut Interactions (DGBI).

Participation in the IBD cohort will last for three years.

干预措施: Colonoscopy w/ biopsy (Diagnostic Test)

Disorders of the Brain-Gut Interactions

Participants will enroll before their initial diagnostic procedure. After pathology results are reported, participants will be categorized based on the assigned diagnoses: Inflammatory Bowel Disease (IBD) [Crohn's disease (CD), ulcerative colitis (UC), and Indeterminate Colitis (IC)] vs Disorders of the Brain-Gut Interactions (DGBI).

-The DGBI cohort will be subdivided into: Esophageal Disorder, Gastroduodenal Disorder, Bowel Disorder, Centrally Mediated Disorders of GI Pain, Gallbladder and Sphincter of Oddi Disorder, Anorectal Disorder, Childhood Functional GI Disorders: Neonate/Toddler, Childhood Functional GI Disorders: Child/Adolescent

Participation in the DGBI cohort will include the initial sample and data collection as well an one further medical record extraction at month 24.

干预措施: Esophagogastroduodenoscopy (EGD) with biopsy (Diagnostic Test)

Disorders of the Brain-Gut Interactions

Participants will enroll before their initial diagnostic procedure. After pathology results are reported, participants will be categorized based on the assigned diagnoses: Inflammatory Bowel Disease (IBD) [Crohn's disease (CD), ulcerative colitis (UC), and Indeterminate Colitis (IC)] vs Disorders of the Brain-Gut Interactions (DGBI).

-The DGBI cohort will be subdivided into: Esophageal Disorder, Gastroduodenal Disorder, Bowel Disorder, Centrally Mediated Disorders of GI Pain, Gallbladder and Sphincter of Oddi Disorder, Anorectal Disorder, Childhood Functional GI Disorders: Neonate/Toddler, Childhood Functional GI Disorders: Child/Adolescent

Participation in the DGBI cohort will include the initial sample and data collection as well an one further medical record extraction at month 24.

干预措施: Colonoscopy w/ biopsy (Diagnostic Test)

结局指标

主要结局

Bio-repository sample collection for spatial transcriptomics

时间窗: 3 years

Collection of blood and stool samples at baseline month 1, month 2, month 3, month 6, month 12, month 24, and month 36. Tissue will be collected at baseline and at any follow-up endoscopy or surgical intervention.

次要结局

  • Paris Classification of Ulcerative Colitis/Indeterminate Colitis(Baseline)
  • Montreal Classification of Ulcerative Colitis/Indeterminate Colitis(Baseline)
  • Physician's Global Assessment (PGA)(3 years)
  • Montreal Classification of Crohn's disease(Baseline)
  • Paris Classification of Crohn's Disease(Baseline)
  • Disorder of Gut-Brain Interaction classification(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Betty Zheng

Assistant Professor, Director of Advanced IBD Fellowship Program

Seattle Children's Hospital

研究点 (2)

Loading locations...

相似试验

Seattle Spatial Transcriptomic Research in... | 临床试验